jesus: 'n geloofsgeneser?

Clicks: 156
ID: 129618
1998
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #113 of 365 articles by views in JAMA pediatrics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 365 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Jesus: A faith-healer? How are we in a modern age to understand the healing wonders of Jesus in the gospel? How must exorcism be understood? The intention of this paper is to indicate that Jesus' exorcisms are to be understood against the background of the stress factors in the first-century Mediterranean world. The propaganda motive, as well as the competitive milieu in which the texts originated, must be kept in mind when interpreting the healings of Jesus. Jesus' exorcisms are embedded in the structure and institutions of his time. The various institutions in the first-century Mediterranean world must not be understood as separate from one another: they are in fact embedded in each other. The healings of Jesus should be understood as healings of empowerment. Jesus empowers people to cope. He gives authentic meaning to peoples' lives on account of their experience of God's presence.
Reference Key
ayres1998htsjesus: Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Johan Ayres;Andries van Aarde
Journal JAMA pediatrics
Year 1998
DOI
10.4102/hts.v54i3/4.1445
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.